Next-generation carbon nanotube electrochemical sensors for liquid biopsy applications

The detection and quantification of circulating tumor DNA (ctDNA) from blood samples offers a non-invasive approach for cancer diagnostics and treatment monitoring. Although high- sensitivity and specificity assays are available based on polymerase chain reaction and next- generation sequencing, cos...

Full description

Saved in:
Bibliographic Details
Main Authors: Samuel Rantataro, Eero Gustafsson, Ilkka Varjos
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Electrochemistry Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1388248125001067
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The detection and quantification of circulating tumor DNA (ctDNA) from blood samples offers a non-invasive approach for cancer diagnostics and treatment monitoring. Although high- sensitivity and specificity assays are available based on polymerase chain reaction and next- generation sequencing, cost of these assays remains very high and results are typically achieved after days from sampling. Contrasting that, we report the development of a highly-sensitive electrochemical sensor assay, which is based on pristine carbon nanotube (CNT) electrodes functionalized with casein blocking layer and sequence-specific probes for ctDNA. The device demonstrated a 0.9 pM limit of detection towards ctDNA-related oligonucleotide sequences in undiluted human plasma, without applying DNA amplification strategy. Additionally, the assay was specific towards the target DNA and did not generate any distinguishable signal when incubated with wildtype sequence at high-concentration (500 pM). Contrasting to many other electrochemical sensor materials and assays that have previously demonstrated high sensitivity, our CNT-based assay provides results in less than an hour with a simple two-step assay. Additionally, the SWCNT sensors are manufactured at mass manufacturing scale, making this platform suitable for point-of-care applications.
ISSN:1388-2481